Systemic lupus erythematosus (SLE ... A total of 15–20% of cases of SLE are diagnosed in children younger than 16 years (childhood-onset lupus). Although there have been few studies directly ...

A common form of lupus is systemic lupus erythematosus. Systemic lupus erythematosus affects the whole body and can attack virtually any part of it, including skin, major organs, hair, muscles ...

Systemic lupus erythematosus (SLE), also known as lupus, is an autoimmune disease that happens when the body’s defence system, which is supposed to help our body fight infections, turns against ...

While childhood-onset lupus is rare ... in pediatric patients were consistent with those in adults with systemic lupus erythematosus (SLE). Benlysta has been approved for use in adult patients ...

After a previously reported positive phase 2 trial in systemic lupus erythematosus (SLE), the TYK2 inhibitor deucravacitinib ...

A new study of more than 2,900 patients provides evidence that it's likely best to use as little corticosteroid medicine as possible when treating people who have lupus pericarditis, a common ...

Research grants funded by the National Institutes of Health (NIH) have been obtained for studies in juvenile arthritis and multiple studies have been performed in patients with childhood systemic ...

CARRA - Childhood Arthritis and Rheumatology Research Alliance ... high-risk pregnancies in patients with antiphospholipid syndrome (APS) with or without systemic lupus erythematosus (SLE). The lead ...

Gazyva is being investigated in children and adolescents with lupus nephritis, people with membranous nephropathy, childhood-onset idiopathic nephrotic syndrome and systemic lupus erythematosus (SLE), ...

New research suggests the use of oral prednisone should be limited in patients with systemic lupus erythematosus with a history of recurrent pericarditis.

Apart from LN, Roche is also evaluating Gazyva in separate late-stage studies for membranous nephropathy, childhood-onset idiopathic nephrotic syndrome and systemic lupus erythematosus indications.